Corvus Pharmaceuticals Inc (CRVS) — Working Capital to Net Assets Ratio
Corvus Pharmaceuticals Inc (CRVS) has a Working Capital to Net Assets ratio of 79.8% as of December 2025. Working capital of $48.83 Million (current assets of $58.21 Million minus current liabilities of $9.38 Million) is measured against net assets of $61.20 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Corvus Pharmaceuticals Inc to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Corvus Pharmaceuticals Inc Working Capital to Net Assets (2014–2025)
This chart shows how Corvus Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 79.8%, reflecting working capital of $48.83 Million against net assets of $61.20 Million USD. Check CRVS goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Corvus Pharmaceuticals Inc (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Corvus Pharmaceuticals Inc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see CRVS stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 79.8% | $48.83 Million | $61.20 Million | $58.21 Million | $9.38 Million | ▲ +21.4 pp |
| 2024 | 58.4% | $19.00 Million | $32.57 Million | $54.41 Million | $35.40 Million | ▲ +3.8 pp |
| 2023 | 54.5% | $21.09 Million | $38.68 Million | $27.96 Million | $6.87 Million | ▼ -4.1 pp |
| 2022 | 58.7% | $32.91 Million | $56.12 Million | $43.66 Million | $10.75 Million | ▼ -4.8 pp |
| 2021 | 63.4% | $61.62 Million | $97.16 Million | $71.31 Million | $9.69 Million | ▲ +17.4 pp |
| 2020 | 46.0% | $33.19 Million | $72.15 Million | $45.34 Million | $12.15 Million | ▼ -51.2 pp |
| 2019 | 97.2% | $69.12 Million | $71.11 Million | $79.34 Million | $10.22 Million | ▲ +0.5 pp |
| 2018 | 96.7% | $106.70 Million | $110.34 Million | $114.60 Million | $7.90 Million | ▲ +2.3 pp |
| 2017 | 94.4% | $80.11 Million | $84.83 Million | $90.06 Million | $9.94 Million | ▼ -1.6 pp |
| 2016 | 96.0% | $127.55 Million | $132.80 Million | $134.90 Million | $7.35 Million | ▲ +393.8 pp |
| 2015 | -297.7% | $92.59 Million | $-31.10 Million | $95.66 Million | $3.07 Million | ▲ +5900.4 pp |
| 2014 | -6198.1% | $9.86 Million | $-159.00K | $12.53 Million | $2.67 Million | — |